FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy

FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy Int Urol Nephrol (2017) 49:1585–1591 DOI 10.1007/s11255-017-1637-4 UROLOGY - ORIGINAL PAPER FDG‑PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy 1 2 1 3 E. E. Fransen van de Putte · E. Vegt · L. S. Mertens · A. Bruining · 1 4 1 1 K. Hendricksen · M. S. van der Heijden · S. Horenblas · B. W. G. van Rhijn Received: 28 April 2017 / Accepted: 5 June 2017 / Published online: 3 July 2017 © Springer Science+Business Media B.V. 2017 Abstract downstaging (pPR or pCR) was identified with 83% sen - Purpose We investigated the accuracy of FDG-PET/CT sitivity and 80% specificity. Tumor pCR was detected with response identification following neoadjuvant or induction 70% sensitivity and 71% specificity. pCR of overall disease chemotherapy (NAIC) for invasive bladder cancer (BC) as (primary tumor and LNs, n = 17) was detected with 67% to better select patients for radical cystectomy (RC). sensitivity and 75% specificity. CSS was positively associ - Methods Between 2010 and 2014, 37 cT1-4N1-3 BC ated with pathologic CR (HR 0.16, p = 0.027), but not with patients received a FDG-PET/CT before and after NAIC metabolic CR (HR 0.560, p = 0.612). followed http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Urology and Nephrology Springer Journals

FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy

Loading next page...
 
/lp/springer_journal/fdg-pet-ct-for-response-evaluation-of-invasive-bladder-cancer-0dIxrsHfvi
Publisher
Springer Netherlands
Copyright
Copyright © 2017 by Springer Science+Business Media B.V.
Subject
Medicine & Public Health; Nephrology; Urology
ISSN
0301-1623
eISSN
1573-2584
D.O.I.
10.1007/s11255-017-1637-4
Publisher site
See Article on Publisher Site

Abstract

Int Urol Nephrol (2017) 49:1585–1591 DOI 10.1007/s11255-017-1637-4 UROLOGY - ORIGINAL PAPER FDG‑PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy 1 2 1 3 E. E. Fransen van de Putte · E. Vegt · L. S. Mertens · A. Bruining · 1 4 1 1 K. Hendricksen · M. S. van der Heijden · S. Horenblas · B. W. G. van Rhijn Received: 28 April 2017 / Accepted: 5 June 2017 / Published online: 3 July 2017 © Springer Science+Business Media B.V. 2017 Abstract downstaging (pPR or pCR) was identified with 83% sen - Purpose We investigated the accuracy of FDG-PET/CT sitivity and 80% specificity. Tumor pCR was detected with response identification following neoadjuvant or induction 70% sensitivity and 71% specificity. pCR of overall disease chemotherapy (NAIC) for invasive bladder cancer (BC) as (primary tumor and LNs, n = 17) was detected with 67% to better select patients for radical cystectomy (RC). sensitivity and 75% specificity. CSS was positively associ - Methods Between 2010 and 2014, 37 cT1-4N1-3 BC ated with pathologic CR (HR 0.16, p = 0.027), but not with patients received a FDG-PET/CT before and after NAIC metabolic CR (HR 0.560, p = 0.612). followed

Journal

International Urology and NephrologySpringer Journals

Published: Jul 3, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from Google Scholar, PubMed
Create lists to organize your research
Export lists, citations
Access to DeepDyve database
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off